Navigation Links
Einstein to utilize electronic medical records system to analyze HIV/AIDS in central Africa
Date:9/8/2011

September 7, 2011 (BRONX, NY) In 2004, the global community acted in earnest to address the HIV/AIDS epidemic in Africa. As a result, millions of Africans are now receiving the same advanced antiretroviral therapy (ART) that has long been available in the developed world. While research shows that AIDS death rates in Africa have stabilized, little is known about the actual deployment and circumstances of treatment.

A consortium led by Albert Einstein College of Medicine of Yeshiva University has received a $4 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to spearhead the Central Africa International Epidemiologic Databases to Evaluate AIDS (CA-IeDEA). CA-IeDEA researchers will work directly with the governments of Burundi and Cameroon, as well as with non-governmental organizations in Rwanda, to collect and analyze the data of nearly 40,000 patients on ART.

The International Epidemiologic Databases to Evaluate AIDS (IeDEA) is a research consortium established in 2005 to address the unique and evolving questions in global HIV/AIDS research through regional and intra-regional observational data. Kathryn Anastos, M.D., co-director of Einstein's Global Health Center and co-principal investigator of the grant, and her team will be among the global team analyzing and publishing on the data produced. One of only seven IeDEA centers around the world, CA-IeDEA will create a robust and flexible database that will enable researchers to examine the real-world practice and results of ART including its impact on reducing cancer and interactions of HIV with other major, deadly diseases that afflict the region, such as malaria.

"Central Africa is a unique region that presents its own set of challenges for effective HIV/AIDS treatment and positive patient outcomes," said Dr. Anastos. "By working with government health leaders in Burundi and Cameroon, our teams hope to contribute to the global understanding of HIV/AIDS treatment, while also helping to improve the care and lives of their residents."

Donald Hoover, Ph.D., of Rutgers, The State University of New Jersey, is co-principal investigator of the grant and will lead and monitor activities pertaining to data development and analysis. Dominic Duggan, Ph.D., of Stevens Institute of Technology, is designing the IT component.

In clinics around Central Africa, the team will deploy and extend OpenMRS, an open-source electronic medical record system that is the focus of a vibrant open-source community. Implementing the system will offer researchers an efficient means to collect consistent data, as well as provide participating clinics in each country with a relatively low-cost healthcare IT solution that the governments may choose to expand as a national initiative.

Dr. Anastos will be responsible for the overall administration and leadership of CA-IeDEA, including developing the research team within each country, building capacity and stimulating epidemiologic brainstorming. As a professor of medicine and of epidemiology & population health at Einstein, she will continue to oversee and lead a range of HIV/AIDS research projects in Rwanda and the Bronx.


'/>"/>

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert  

Related medicine news :

1. Einstein scientists find crucial molecule involved in spread of breast cancer
2. Einstein secures $11 million to continue research on brain aging and Alzheimers disease
3. Einstein Montefiore lung specialist to receive award for work with 9/11 rescue workers
4. Feinstein scientists identify abnormal disease pathway in dystonia
5. Susan Band Horwitz, Ph.D., of Einstein, receives lifetime achievement award in cancer research
6. Einstein-Montefiore researcher will test nanoparticles against pancreatic cancer
7. ALBERT EINSTEIN COLLEGE OF MEDICINE HELPS ADDRESS NEED FOR IMPROVED CANCER CARE IN RURAL AMERICA
8. Feinstein Institute to share $5M US Department of Defense grant
9. Einstein scientist awarded $4 million to develop genetic strategy to combat tuberculosis
10. Einstein awarded NIH grant to study drug-resistant TB
11. NIH awards $10M to Einstein for diabetes research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Einstein to utilize electronic medical records system to analyze HIV/AIDS in central Africa
(Date:5/27/2016)... Columbia, SC (PRWEB) , ... May 27, 2016 , ... ... launched a line of classic American timber frame barn kits, which can be found ... are inspired by historic American barn plans, and they highlight the craftsmanship of ...
(Date:5/27/2016)... ... , ... With over 60 percent of acute stroke survivors being left unable ... aid in the rehabilitation process has steadily increased. Ekso Bionics had been working to ... to stroke. , Ekso Bionics has now received clearance from the U.S. Food and ...
(Date:5/27/2016)... Killeen, Texas (PRWEB) , ... May 27, 2016 , ... ... with satisfying Army body fat composition regulations. This is the first time that ... are normally screened at least every six months to ensure they meet the prescribed ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... the pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center ... proof of successfully certified products, services and staff. , Validation Center is ISO17025 ...
(Date:5/26/2016)... California (PRWEB) , ... May 26, 2016 , ... ... associated with discovery of thousands of defective respirators, according to court documents and ... the case of William and Becky Tyler v. American Optical Corporation, Case No. ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
(Date:5/25/2016)... und GERMANTOWN, Maryland , May ... mit Therawis bedient dringenden ... QIAGEN N.V. (NASDAQ: QGEN ... eine Lizenz- und Entwicklungsvereinbarung mit Therawis Diagnostics GmbH ... Onkologie eingegangen zu sein. Ein erstes Projekt wird ...
(Date:5/25/2016)... 25, 2016  Zymo Research Corp. announced today ... reference materials that help researchers obtain the most ... analyses. The rapid growth of the study of ... have standard methods to improve the reproducibility and ... exist at every step of the measurement process ...
Breaking Medicine Technology: